 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

For the last three days, A.I.dvisor has detected that ABOS's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Acumen Pharmaceuticals (ABOS, $4.15) Aroon Indicator entered a Downtrend on September 29, 2023.

Acumen Pharmaceuticals (ABOS, $4.17) Aroon Indicator entered a Downtrend on September 28, 2023.

Acumen Pharmaceuticals (ABOS, $4.21) Aroon Indicator entered a Downtrend on September 27, 2023.

Acumen Pharmaceuticals (ABOS, $4.29) Aroon Indicator entered a Downtrend on September 26, 2023.

Acumen Pharmaceuticals (ABOS, $4.24) Aroon Indicator entered a Downtrend on September 25, 2023.

Acumen Pharmaceuticals (ABOS, $4.45) Aroon Indicator entered a Downtrend on September 22, 2023.

Acumen Pharmaceuticals (ABOS, $4.91) Aroon Indicator entered a Downtrend on September 20, 2023.

Acumen Pharmaceuticals (ABOS, $5.12) Aroon Indicator entered a Downtrend on September 18, 2023.

CHARLOTTESVILLE, Va. and CARMEL, Ind., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that...

Acumen Pharmaceuticals to Participate in the Cantor Global Healthcare Conference

Acumen Pharmaceuticals (ABOS, $5.53) Aroon Indicator entered a Downtrend on September 15, 2023.

Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.

Watchers	1,127
52-Wk Low	$3.52
52-Wk High	$11.31

Market Cap	$240.15M
Volume (M)	229,963.00
52-Wk High	$11.31
52-Wk Low	$3.52

ABOS Acumen Pharmaceuticals Inc

About

Feed

News

Earnings

Fundamentals